These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9194688)

  • 1. Pharmacologic inhibition of transglutaminase-induced cross-linking of Alzheimer's amyloid beta-peptide.
    Zhang W; Johnson BR; Bjornsson TD
    Life Sci; 1997; 60(25):2323-32. PubMed ID: 9194688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical demonstration of tissue transglutaminase in amyloid plaques.
    Zhang W; Johnson BR; Suri DE; Martinez J; Bjornsson TD
    Acta Neuropathol; 1998 Oct; 96(4):395-400. PubMed ID: 9797004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiation.
    Hartley DM; Zhao C; Speier AC; Woodard GA; Li S; Li Z; Walz T
    J Biol Chem; 2008 Jun; 283(24):16790-800. PubMed ID: 18397883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
    Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
    Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation.
    Mao F; Huang L; Luo Z; Liu A; Lu C; Xie Z; Li X
    Bioorg Med Chem; 2012 Oct; 20(19):5884-92. PubMed ID: 22944335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
    Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
    Zheng H; Amit T; Bar-Am O; Fridkin M; Youdim MB; Mandel SA
    J Alzheimers Dis; 2012; 30(1):1-16. PubMed ID: 22387411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tissue transglutaminase on beta -amyloid1-42-induced apoptosis.
    Wakshlag JJ; Antonyak MA; Boehm JE; Boehm K; Cerione RA
    Protein J; 2006 Jan; 25(1):83-94. PubMed ID: 16721663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue transglutaminase-mediated glutamine deamidation of beta-amyloid peptide increases peptide solubility, whereas enzymatic cross-linking and peptide fragmentation may serve as molecular triggers for rapid peptide aggregation.
    Schmid AW; Condemi E; Tuchscherer G; Chiappe D; Mutter M; Vogel H; Moniatte M; Tsybin YO
    J Biol Chem; 2011 Apr; 286(14):12172-88. PubMed ID: 21300794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugates of desferrioxamine and aromatic amines improve markers of iron-dependent neurotoxicity.
    Carvalho RRV; Peres TV; Liria CW; Machini MT; Aschner M; Espósito BP
    Biometals; 2021 Apr; 34(2):259-275. PubMed ID: 33389339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids.
    Sun Y; Chen J; Chen X; Huang L; Li X
    Bioorg Med Chem; 2013 Dec; 21(23):7406-17. PubMed ID: 24128814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-linking of ZP2 and ZP3 by transglutaminase is required for the formation of the outer layer of fertilization envelope of carp egg.
    Chang YS; Wang YW; Huang FL
    Mol Reprod Dev; 2002 Oct; 63(2):237-44. PubMed ID: 12203834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development§.
    Milelli A; De Simone A; Ticchi N; Chen HH; Betari N; Andrisano V; Tumiatti V
    Curr Med Chem; 2017; 24(32):3522-3546. PubMed ID: 28294041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clicked tacrine conjugates as acetylcholinesterase and β-amyloid directed compounds.
    Ouberai M; Brannstrom K; Vestling M; Olofsson A; Dumy P; Chierici S; Garcia J
    Org Biomol Chem; 2011 Feb; 9(4):1140-7. PubMed ID: 21152577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease.
    Xie SS; Wang X; Jiang N; Yu W; Wang KD; Lan JS; Li ZR; Kong LY
    Eur J Med Chem; 2015 May; 95():153-65. PubMed ID: 25812965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorescence anisotropy-based assay for determining the activity of tissue transglutaminase.
    Hauser C; Wodtke R; Löser R; Pietsch M
    Amino Acids; 2017 Mar; 49(3):567-583. PubMed ID: 26886924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transglutaminase substrates and inhibitors on the motility of demembranated reactivated spermatozoa.
    de Lamirande E; Gagnon C
    Gamete Res; 1989 Feb; 22(2):179-92. PubMed ID: 2565284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.
    Romero A; Marco-Contelles J
    Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents.
    Roldán-Peña JM; Alejandre-Ramos D; López Ó; Maya I; Lagunes I; Padrón JM; Peña-Altamira LE; Bartolini M; Monti B; Bolognesi ML; Fernández-Bolaños JG
    Eur J Med Chem; 2017 Sep; 138():761-773. PubMed ID: 28728108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.